Overview
Lp(a) consists of an LDL-like particle covalently bound to apolipoprotein(a).
Clinical Importance
Once-in-lifetime or selected risk-enhancing lipid assessment
Family history of premature ASCVD
Specimen Requirements
- Specimen: serum or lithium heparin plasma (method- and analyzer-dependent; follow the performing laboratory)
- Tube: gold/SST (serum separator) or green-top lithium heparin as validated locally
- Handling: invert gently; allow SST to clot fully before centrifugation; separate promptly
- Storage: refrigerate serum/plasma if testing is delayed per analyte stability limits
- Stability: analyte-specific; do not exceed institutional or manufacturer time/temperature limits
- Fasting: follow institutional/protocol fasting requirements when the ordered pathway requires fasting
Analytical Method
Immunoassays ideally calibrated in nmol/L and minimally sensitive to apo(a) isoform size; mg/dL assays remain common.
Instruments Used
Automated analyzers
- Roche Cobas chemistry and immunoassay systems
- Abbott Alinity / Architect chemistry and immunoassay systems
- Siemens Healthineers Atellica / ADVIA chemistry and immunoassay systems
- Beckman Coulter AU / DxC chemistry systems
- Beckman Coulter Access / DxI immunoassay systems
- Mindray BS-series chemistry analyzers
- Ortho Clinical Diagnostics Vitros systems
- Thermo Fisher / Indiko and related chemistry platforms
- Randox clinical chemistry systems
Manual methods
- Manual spectrophotometric/immunoassay methods in selected reference or backup settings
Reference Values
Typical adult SI examples below follow widely published international clinical chemistry practice (e.g., Tietz; Henry's). Always interpret against the method- and demographics-specific interval printed on the patient report (CLSI EP28-A3c). Neonatal, pediatric, pregnancy, and assay-generation intervals differ.
Risk thresholds are guideline-dependent (often approximately >50 mg/dL or >125 nmol/L cited as risk-enhancing; assay-specific). Use the reporting laboratory’s units and cut-points.
Interpretation
Common Causes of Increased Results
- Elevated Lp(a) is a genetic ASCVD risk enhancer
Common Causes of Decreased Results
- Low Lp(a) is common and favorable from a risk-marker standpoint
Clinical Significance
- Risk-enhancing lipid testing
Factors Affecting Results
Pre-analytical
- Hemolysis, lipemia, or icterus (analyte- and method-dependent interference)
- IV fluid contamination or draw above an infusion
- Prolonged tourniquet time; delayed separation of cells
- Wrong tube additive or incomplete clotting of SST
Analytical
- Isoform-sensitive assay bias if not carefully calibrated
- mg/dL vs nmol/L unit confusion
Post-analytical
- Treating Lp(a) as a day-to-day diet-responsive lipid
Advantages and Limitations
Advantages
- Stable genetic risk marker
Limitations
- Assay standardization still evolving
- Limited lifestyle responsiveness
Clinical Pearls
Measure Lp(a) in nmol/L when your method allows; isoform bias is the quiet enemy of mg/dL assays.
References
Authoritative textbooks, guidelines, and reviews supporting this laboratory test reference. Verify reference intervals, critical limits, and method details against institutional protocols and current guideline editions.
Textbooks
- Rifai N, Horvath AR, Wittwer CT, eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 8th ed. Elsevier; 2022.
- McPherson RA, Pincus MR. Henry's Clinical Diagnosis and Management by Laboratory Methods. 24th ed. Elsevier; 2021.
- Bishop ML, Fody EP, Schoeff LE. Clinical Chemistry: Principles, Techniques, and Correlations. 9th ed. Jones & Bartlett; 2022.
CLSI and Professional Guidelines
- International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Recommendations and reference measurement systems for clinical chemistry measurands (verify current IFCC documents for the analyte).
- Clinical and Laboratory Standards Institute. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Standard. CLSI document EP28-A3c. CLSI; 2010.
- Clinical and Laboratory Standards Institute. Collection of Diagnostic Venous Blood Specimens. CLSI standard GP41. CLSI.
- American Diabetes Association. Standards of Care in Diabetes. Diabetes Care (annual update).
- Kidney Disease: Improving Global Outcomes (KDIGO). Clinical Practice Guideline for Evaluation and Management of Chronic Kidney Disease.
- American Association for the Study of Liver Diseases (AASLD). Practice guidance related to evaluation of abnormal liver chemistries / liver disease laboratory evaluation (verify current AASLD publication and institutional adoption).
- Grundy SM, et al. 2018 AHA/ACC Guideline on the Management of Blood Cholesterol. Circulation. 2019.
Frequently Asked Questions
Common questions about using this Lipoprotein(a) laboratory test Medical Laboratory Library reference in Medical Laboratory Science education.
What is the Lipoprotein(a) laboratory test reference used for?
This Medical Laboratory Library page summarizes the clinical importance of Lipoprotein(a). Review the Clinical Importance section for why the test is ordered in laboratory medicine practice.
Where can I find Lipoprotein(a) specimen requirements?
See the Specimen Requirements section on this page for specimen information related to Lipoprotein(a). Confirm collection details against your laboratory protocol.
Where are Lipoprotein(a) reference values listed?
See the Reference Values section on this Laboratory Library page. Reference ranges can vary by method and population, so verify intervals with your laboratory.
How do I interpret Lipoprotein(a) results?
Use the Interpretation section for laboratory interpretation framing, including increased and decreased result patterns when provided. Do not treat educational text as a patient-specific diagnosis.
What analytical method is used for Lipoprotein(a)?
See the Analytical Method section for principle and method notes. Method details may differ by instrument and institutional SOP.
Are related laboratory tests linked from Lipoprotein(a)?
Yes. The Related Laboratory Tests section lists connected references for continued lookup in the Medical Laboratory Library.
How can I continue learning after reading Lipoprotein(a)?
Use Continue learning links on this page for related Academy lessons, medical laboratory quizzes, or laboratory case studies when available for this Clinical Chemistry topic.
What are the clinical pearls for Lipoprotein(a)?
See the Clinical Pearls section for concise laboratory practice notes associated with Lipoprotein(a). Apply pearls alongside institutional protocols.
Reading progress
Awards XP once after you have meaningfully reviewed this article.